Transporter-Guided Delivery of Nanoparticles to Improve Drug Permeation across Cellular Barriers and Drug Exposure to Selective Cell Types
Longfa Kou(Wenzhou Medical University), Vadivel Ganapathy(Texas Tech University)
Cited by 295
Related Papers
GPR109A Is a G-protein–Coupled Receptor for the Bacterial Fermentation Product Butyrate and Functions as a Tumor Suppressor in Colon
|Cancer Research|2009|765
Dual targeting of<scp>l</scp>-carnitine-conjugated nanoparticles to OCTN2 and ATB<sup>0,+</sup>to deliver chemotherapeutic agents for colon cancer therapy
|Drug Delivery|2017|86
Cotransporting Ion is a Trigger for Cellular Endocytosis of Transporter‐Targeting Nanoparticles: A Case Study of High‐Efficiency SLC22A5 (OCTN2)‐Mediated Carnitine‐Conjugated Nanoparticles for Oral Delivery of Therapeutic Drugs
|Advanced Healthcare Materials|2017|80
<scp>L</scp>-Carnitine-conjugated nanoparticles to promote permeation across blood–brain barrier and to target glioma cells for drug delivery via the novel organic cation/carnitine transporter OCTN2
|Artificial Cells Nanomedicine and Biotechnology|2017|80